Title : Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDAC.

Pub. Date : 2019 May 16

PMID : 31100813






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Here we tested combinations of fendiline with gemcitabine, visudyne (a YAP1 inhibitor) or tivantinib (ARQ197, a c-Met inhibitor) for their effectiveness in overcoming growth and oncogenic characteristics of PDAC cells. Fendiline MET proto-oncogene, receptor tyrosine kinase Homo sapiens